The Inherent Invasiveness of Cerebral Gliomas: Implications for Clinical Management
Overview
Authors
Affiliations
Cui Y, Zeng W, Jiang H, Ren X, Lin S, Fan Y Front Neurol. 2020; 11:592155.
PMID: 33343496 PMC: 7747764. DOI: 10.3389/fneur.2020.592155.
Chatzikonstantinou G, Zamboglou N, Archavlis E, Strouthos I, Zoga E, Milickovic N Strahlenther Onkol. 2018; 194(12):1171-1179.
PMID: 30203110 DOI: 10.1007/s00066-018-1358-3.
Sander P, Mostafa H, Soboh A, Schneider J, Pala A, Baron A Oncotarget. 2017; 8(21):35124-35137.
PMID: 28410232 PMC: 5471040. DOI: 10.18632/oncotarget.16703.
In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
Morrone F, Oliveira D, Gamermann P, Stella J, Wofchuk S, Wink M BMC Cancer. 2006; 6:226.
PMID: 16995949 PMC: 1592110. DOI: 10.1186/1471-2407-6-226.
Increased resistance of glioma cell lines to extracellular ATP cytotoxicity.
Morrone F, Horn A, Stella J, Spiller F, Sarkis J, Salbego C J Neurooncol. 2005; 71(2):135-40.
PMID: 15690128 DOI: 10.1007/s11060-004-1383-1.